Metraipolis › archive › dc_076ecdb90b6d

Inferring tumor immune microenvironment -related risk states from pretreatment H&E pathomics and clinical biomarkers to predict checkpoint inhibitor… — Europe PMC PMID:41798925

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41798925
DOI
10.3389/fimmu.2026.1792179
License (as archived)
solo-consultazione
Archived
2026-11-05T15:20:14.519Z
SHA-256 of the archived text
43179924e8fd221bfc60d28884d0476b951aaabcedbb87c4ce19fdee80725121
Stable URL of this page
https://metraipolis.com/documento/dc_076ecdb90b6d

How to cite

Inferring tumor immune microenvironment -related risk states from pretreatment H&E pathomics and clinical biomarkers to predict checkpoint inhibitor… — Europe PMC PMID:41798925 — Europe PMC (en), https://europepmc.org/article/MED/41798925 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_076ecdb90b6d (Metraipolis archive dc_076ecdb90b6d, sha256 43179924e8fd221bfc60d28884d0476b951aaabcedbb87c4ce19fdee80725121)
BibTeX
@misc{dc076ecdb90b6d,
  title = {Inferring tumor immune microenvironment -related risk states from pretreatment H&E pathomics and clinical biomarkers to predict checkpoint inhibitor… — Europe PMC PMID:41798925},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41798925},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_076ecdb90b6d; sha256 43179924e8fd221bfc60d28884d0476b951aaabcedbb87c4ce19fdee80725121},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41798925. Agents can read the archived copy with the MCP tool read_document.